Skip to main content Skip to section navigation Skip to footer

Investors Back To Corporate Site >

Investors
Overview
Company
News & Events
- Press Releases
- IR Calendar
Stock
- Quote
- Historical Data
Financials
Analyst Coverage
Governance

NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg

Learn More

NOW APPROVED

Journey Medical Corporation Announces the U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg for Treatment of Papulopustular Rosacea.

Learn More

Presentations

Company

About Us
Management Team
Presentations
Contacts
FAQ

Journey Medical Corporate Overview

Email Alerts
Contacts
RSS News Feed

©2025 Journey Medical Corporation. All Rights Reserved.

Privacy Policy Terms of Use Sitemap

Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

We use cookies to offer you a better browsing experience, including personalized advertising. By continuing to use the site you agree to their use.